15-May-2018 to 14-Jul-2018 (EST)
Downstream Process Development
Rockville, MD, USA
Full Time - Non-Exempt
At Novavax, a clinical-stage vaccine company, we are creating tomorrow's vaccines today! We seek to attract, develop, and retain talented people who share our passion for science, medicine, and human health. We foster an environment of teamwork and collaboration, built on a culture that values and appreciates its employees. We are a fast-paced company that provides employees with opportunities to achieve personal and professional goals while also maintaining a balance between work and personal life.
We are seeking a highly detail-oriented and organized individual to support Process Development with the manufacture of buffers and media. Additionally, this individual would be responsible for managing the PD inventory program.
Responsibilities include but are not limited to:
Main function will be to perform the day to day activities in the Solutions Preparation Area: preparation of buffers, preparation of cell culture media/feeds, calibration of pH and conductivity meters/probes, transport of glassware, scheduling equipment maintenance, etc., to support all of process development.
Maintain thorough documentation of solution formulations and completed orders.
Learn and perform downstream operations and supporting downstream activities as time permits.
Organize Solutions Prep and Inventory areas for maximum space utilization.
Perform other duties as assigned (i.e. support of Cell Culture or Purification operations).
1-2 years in biologics laboratory or cGMP manufacturing area preferred.
Highly organized and detail-oriented.
Ability to function in a highly dynamic environment.
Excellent verbal, written, and interpersonal communication skills.
Excellent record keeping abilities.
Experience with Microsoft Office applications.
Novavax, Inc. is a clinical-stage biotechnology company committed to delivering novel products to prevent a broad range of infectious diseases. Using innovative proprietary recombinant nanoparticle vaccine technology, we produce vaccine candidates to efficiently and effectively respond to both known and emerging disease threats. Our vaccine candidates are genetically engineered three-dimensional nanostructures that incorporate recombinant proteins critical to disease pathogenesis.
Our product pipeline targets a variety of infectious diseases, with clinical vaccine candidates for respiratory syncytial virus (RSV) and Ebola virus (EBOV), and preclinical programs for Zika virus (ZIKV), seasonal influenza and a combination respiratory vaccine candidate, as well as other infectious disease vaccine candidates.
Novavax, Inc. is headquartered in Gaithersburg, Maryland with additional facilities in Rockville, Maryland and Uppsala, Sweden. Novavax is traded on the Nasdaq Stock Market under the symbol NVAX and is dedicated to developing novel vaccines to address infectious disease.
Novavax, Inc. offers a base salary, annual bonus, stock options, professional career development/growth opportunities, and a comprehensive benefits package including medical, dental, vision, Rx, STD, LTD, Life, Optional Life, 401(k) plan.
Equal Opportunity Employer/Veterans/Disabled
Novavax, Inc. is an equal opportunity employer. All qualified applicants will receive consideration for employment without regard to race, color, religion, sex, sexual orientation, gender identity, national origin, or protected veteran status and will not be discriminated against on the basis of disability.
Novavax, Inc. (Nasdaq: NVAX) is a clinical-stage biopharmaceutical company creating recombinant protein nanoparticle vaccines to address a broad range of infectious diseases. The company is developing a portfolio of vaccine candidates targeting seasonal and pandemic influenza (H5N1), a vaccine designed to protect children and the elderly against respiratory syncytial virus (RSV), rabies and other candidates.